People · Operator
Named in public records as an officer, director or promoter · active 2017–2017 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| MPX Bioceutical Corp | — | Pharmaceuticals | Seed | $2.5M | $94.3M | 2017 |
David S. McLaren at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David S. McLaren on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert R. Galvin | 1 | 2 |
| Richard S. Segerblom | 1 | 1 |
| W. Scott Boyes | 1 | 1 |
| Elizabeth M. Stavola | 1 | 1 |
| Andrew R. Ryan | 1 | 1 |
| Miles D. Thompson | 1 | 1 |
| Randall G. Stafford | 1 | 1 |
| Jeremy S. Budd | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.